title: Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.
abstract: Anthracyclines have been widely used in children and adults to treat hematologic malignancies, soft-tissue sarcomas, and solid tumors. However, anthracyclines come with both short- and long-term cardiotoxic effects, ranging from occult changes in myocardial structure and function to severe cardiomyopathy and heart failure that may result in cardiac transplantation or death. Here, we review the progress made over the past two decades in understanding the molecular and genetic basis of anthracycline-induced cardiotoxicity; detecting and monitoring myocardial dysfunction; using adjunct cardioprotectant therapies, such as dexrazoxane; and improving cardioprotection with agents such as liposomal and pegylated doxorubicin. Despite this increased understanding, preventing drug-induced cardiotoxicity while maintaining oncologic efficacy to achieve the highest quality of life over a lifespan remain cornerstones of successful anthracycline chemotherapy during childhood.
authors.affiliation: Department of Pediatrics, Division of Pediatric Cardiology, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Shashi
authors.initials: S
authors.lastname: Raj
authors.forename: Vivian I
authors.initials: VI
authors.lastname: Franco
authors.forename: Steven E
authors.initials: SE
authors.lastname: Lipshultz
references.citation: J Natl Cancer Inst. 2008 Aug 6;100(15):1058-67
references.pmid: 18664656
references.citation: Semin Oncol. 1998 Aug;25(4 Suppl 10):37-42
references.pmid: 9768822
references.citation: J Clin Oncol. 2013 Oct 10;31(29):3673-80
references.pmid: 24002505
references.citation: J Am Coll Cardiol. 2013 Apr 9;61(14):1539-47
references.pmid: 23500246
references.citation: Circulation. 2010 Jan 19;121(2):276-92
references.pmid: 20038740
references.citation: Pediatrics. 2005 Jun;115(6):1613-22
references.pmid: 15930224
references.citation: Pediatr Cardiol. 2013 Apr;34(4):826-34
references.pmid: 23080542
references.citation: Support Care Cancer. 2008 May;16(5):437-45
references.pmid: 18197426
references.citation: Br J Haematol. 2005 Dec;131(5):561-78
references.pmid: 16351632
references.citation: Ann Oncol. 2002 Jun;13(6):819-29
references.pmid: 12123328
references.citation: J Clin Oncol. 2004 Mar 1;22(5):820-8
references.pmid: 14990637
references.citation: J Clin Oncol. 2002 Dec 1;20(23):4517-22
references.pmid: 12454107
references.citation: Lancet Oncol. 2010 Oct;11(10):950-61
references.pmid: 20850381
references.citation: Nat Med. 2012 Nov;18(11):1639-42
references.pmid: 23104132
references.citation: Cancer. 2013 Oct 1;119(19):3555-62
references.pmid: 23861158
references.citation: BMJ. 2009 Dec 08;339:b4606
references.pmid: 19996459
references.citation: Hum Mol Genet. 1998 Sep;7(9):1431-5
references.pmid: 9700198
references.citation: N Engl J Med. 2008 May 15;358(20):2148-59
references.pmid: 18480207
references.citation: Eur J Cancer. 2006 Dec;42(18):3191-8
references.pmid: 16987655
references.citation: Expert Opin Pharmacother. 2007 Jun;8(8):1039-58
references.pmid: 17516870
references.citation: Circulation. 2004 Jun 8;109(22):2749-54
references.pmid: 15148277
references.citation: Pediatr Hematol Oncol. 2010 Oct;27(7):546-57
references.pmid: 20795769
references.citation: Cardiovasc Toxicol. 2007;7(2):114-21
references.pmid: 17652815
references.citation: J Mol Cell Cardiol. 1997 Sep;29(9):2415-30
references.pmid: 9299365
references.citation: J Clin Oncol. 2012 Apr 1;30(10):1042-9
references.pmid: 22370326
references.citation: Cancer Chemother Pharmacol. 2001 Dec;48(6):423-8
references.pmid: 11800021
references.citation: JAMA. 2010 Jul 14;304(2):172-9
references.pmid: 20628130
references.citation: Crit Rev Oncol Hematol. 1998 Jan;27(1):53-68
references.pmid: 9548017
references.citation: Eur J Cancer. 2013 Sep;49(13):2900-9
references.pmid: 23706982
references.citation: Leukemia. 2010 Feb;24(2):355-70
references.pmid: 20016527
references.citation: Circulation. 2013 Oct 22;128(17):1927-95
references.pmid: 24081971
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2013-22
references.pmid: 20647396
references.citation: Heart. 2008 Apr;94(4):525-33
references.pmid: 18347383
references.citation: Adolesc Med. 2002 Feb;13(1):161-9, viii
references.pmid: 11841962
references.citation: Br J Cancer. 2004 Jul 5;91(1):37-44
references.pmid: 15162142
references.citation: J Clin Oncol. 2012 May 1;30(13):1429-37
references.pmid: 22473161
references.citation: Br J Cancer. 2006 Sep 4;95(5):571-80
references.pmid: 16880787
references.citation: Mol Cell Biochem. 2002 May-Jun;234-235(1-2):119-24
references.pmid: 12162424
references.citation: J Clin Oncol. 2010 Mar 10;28(8):1308-15
references.pmid: 20142603
references.citation: Curr Treat Options Cardiovasc Med. 2001 Dec;3(6):493-505
references.pmid: 11696269
references.citation: J Mol Cell Cardiol. 2006 Sep;41(3):389-405
references.pmid: 16879835
references.citation: J Clin Oncol. 2012 Apr 1;30(10):1050-7
references.pmid: 22393080
references.citation: Pediatr Blood Cancer. 2013 Apr;60(4):616-20
references.pmid: 22948886
references.citation: Cancer. 2003 Jun 1;97(11):2869-79
references.pmid: 12767102
references.citation: J Clin Oncol. 1997 Apr;15(4):1544-52
references.pmid: 9193351
references.citation: Eur J Cancer. 2009 Nov;45(17):3027-34
references.pmid: 19744853
references.citation: J Clin Oncol. 1998 Feb;16(2):545-50
references.pmid: 9469339
references.citation: Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603
references.pmid: 22744937
references.citation: Circ Cardiovasc Imaging. 2013 Nov;6(6):873-80
references.pmid: 24097420
references.citation: Eur J Cancer. 2011 Jun;47(9):1373-9
references.pmid: 21514146
references.citation: Oncogene. 2004 Sep 16;23(42):7018-30
references.pmid: 15273722
references.citation: Pediatr Blood Cancer. 2005 Jun 15;44(7):600-6
references.pmid: 15856486
references.citation: JAMA. 1991 Sep 25;266(12):1672-7
references.pmid: 1886191
references.citation: J Clin Oncol. 2007 Feb 10;25(5):493-500
references.pmid: 17290056
references.citation: N Engl J Med. 1995 Jun 29;332(26):1738-43
references.pmid: 7760889
references.citation: J Heart Lung Transplant. 2004 Jul;23(7):832-8
references.pmid: 15261177
references.citation: J Clin Oncol. 2010 Mar 10;28(8):1276-81
references.pmid: 20142585
references.citation: N Engl J Med. 2004 Jul 8;351(2):145-53
references.pmid: 15247354
references.citation: Pediatr Blood Cancer. 2013 Apr;60(4):663-8
references.pmid: 23255294
references.citation: Cancer Res. 2000 Apr 1;60(7):1789-92
references.pmid: 10766158
references.citation: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005006
references.pmid: 20238335
references.citation: Ann Intern Med. 1979 Nov;91(5):710-7
references.pmid: 496103
references.citation: J Clin Oncol. 1997 Jan;15(1):61-8
references.pmid: 8996125
references.citation: Pediatrics. 2012 Dec;130(6):1003-11
references.pmid: 23166343
references.citation: N Engl J Med. 1991 Mar 21;324(12):808-15
references.pmid: 1997853
references.citation: J Clin Oncol. 2005 Apr 20;23(12):2629-36
references.pmid: 15837978
references.citation: J Pathol. 2005 Dec;207(4):436-44
references.pmid: 16278810
references.citation: Semin Oncol. 1998 Aug;25(4 Suppl 10):72-85
references.pmid: 9768828
references.citation: Cancer Chemother Pharmacol. 2011 Jun;67(6):1381-8
references.pmid: 20809120
references.citation: Biochim Biophys Acta. 1999 Apr 21;1411(1):201-5
references.pmid: 10216166
references.citation: Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9
references.pmid: 23109647